2024 annual financial data
Heron Therapeutics 2024 Operating margin
Direct answer
Operating margin was -7.99%.
Operating income was -11,528,000 USD and net income was -13,580,000 USD.
Operating cash flow was -22,529,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 144,285,000 USD
- Operating income
- -11,528,000 USD
- Net income
- -13,580,000 USD
- Operating cash flow
- -22,529,000 USD